Answers are grounded in this paper and cite their sources.
Clinical report demonstrates immediate treatment responses to closed-loop spinal cord stimulation in trial patients, suggesting feasible early responder prediction.
Drawbacks of fixed-output spinal cord stimulation (SCS) screening trials may lead to compromised trial outcomes and poor predictability of long-term success. Evoked compound action potential (ECAP) dose-controlled closed-loop (CL) SCS allows objective confirmation of therapeutic neural activation and pulse-to-pulse stimulation adjustment. We report on the immediate patient-reported and neurophysiologic treatment response post-physiologic CL-SCS and feasibility of early SCS trial responder prediction.
No takes yet. Share an insight, caveat, or question.
Pope et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: